EUVIMEDEUVIMED entdecken
Crossref

Use of cessation products, e‐cigarettes and cigarette cessation outcomes among adults with substance use problems: Results from 2013–2021 (Waves 1–6) of the Population Assessment of Tobacco and Health (PATH) Study

Olufemi Erinoso iD, Karin Kasza iD, Christine E Sheffer iD, Andrew Hyland iD, Jennifer Pearson iD

Addiction · 2025-10 · 120 (10) · 2080-2093

DOI: 10.1111/add.70098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction, online erschienen am 26.05.2025. Verfasst von Olufemi Erinoso und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Behavior, Policy and Administration Sciences, University of Nevada, Reno, NV, USA. Hauptthemen laut MEDLINE: Smoking Cessation, Electronic Nicotine Delivery Systems, Tobacco Use Cessation Devices, Substance-Related Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Institutes of Health (NIH) funded Mountain West Clinical & Translational Research Infrastructure Network (MW CTR-IN) Program subaward to Dr. Jennifer….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The aim of this study was to examine how prior use of cessation products and daily electronic nicotine delivery systems (ENDS) use was related to past‐month cigarette abstinence between and within substance use problems (SUPs) categories. Furthermore, we measured past‐year use of cessation products and ENDS among people who smoke cigarettes with high and moderate SUPs compared with those without. Design, setting, participants Longitudinal study using data from the USA‐based Population Assessment of Tobacco and Health (PATH) Study Waves 1–6, collected between 2013/14 and 2021. Data were from adults (ages 18+) who smoked cigarettes in the past‐month baseline wave of each wave‐pair.

Measurements

The predictor was SUP severity (no/low, moderate and high) as assessed using the Global Appraisal of Individual Needs –Short Screener (GAIN‐SS). Outcomes at follow‐up were: 1. past‐month cigarette abstinence and 2. use of cessation aids [any past‐year use of counseling, nicotine replacement therapies (NRTs) and medications] and past‐year daily ENDS use. We used generalized estimating equation models (GEE) to examine the relationship between SUP status and the outcomes. All models were weighted and adjusted for age, sex, race/ethnicity and daily cigarette use.

Findings

Our results show no statistically significant differences in the use of counseling, medications and daily ENDS at follow‐up between individuals by their SUP status. However, individuals with high SUP severity (vs no/low) had higher odds of past‐year use of NRTs [adjusted odds ratio (aOR) = 1.36; 95% confidence interval (CI) = 1.13−1.64]. Furthermore, individuals with high SUPs (aOR = 0.49; 95% CI = 0.37−0.64) had lower odds of past‐month cigarette abstinence at follow‐up compared with those with no/low severity. Among individuals with high SUP, 2.88%, 9.42%, 5.77% and 5.49% used counseling, NRTs, cessation medications and daily ENDS, respectively.

Conclusion

People with high‐severity substance use problems appear to have lower cigarette abstinence than people with low‐severity substance use problems, despite no statistically significant differences in the use of most cessation aids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationElectronic Nicotine Delivery SystemsTobacco Use Cessation DevicesSubstance-Related DisordersCigarette SmokingVapingHumansMaleFemaleAdultMiddle AgedLongitudinal StudiesUnited StatesYoung AdultAdolescent

Stichwörter der Autor:innen

NRTscessationcigaretteequitye‐cigarettesmedicationssubstance use

Autor:innen und Institutionen

  • Department of Health Behavior, Policy and Administration Sciences, University of Nevada, Reno, NV, USA.
  • Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

ORCID-Profile: Olufemi Erinoso, Karin Kasza, Christine E Sheffer, Andrew Hyland, Jennifer Pearson

Förderung

  • National Institutes of Health (NIH) funded Mountain West Clinical & Translational Research Infrastructure Network (MW CTR-IN) Program subaward to Dr. Jennifer…

Zitieren

APA

Erinoso, O., Kasza, K., Sheffer, C. E., Hyland, A., & Pearson, J. (2025). Use of cessation products, e‐cigarettes and cigarette cessation outcomes among adults with substance use problems: Results from 2013–2021 (Waves 1–6) of the Population Assessment of Tobacco and Health (PATH) Study. Addiction, 120(10), 2080-2093. https://doi.org/10.1111/add.70098

Vancouver

Erinoso O, Kasza K, Sheffer CE, Hyland A, Pearson J. Use of cessation products, e‐cigarettes and cigarette cessation outcomes among adults with substance use problems: Results from 2013–2021 (Waves 1–6) of the Population Assessment of Tobacco and Health (PATH) Study. Addiction. 2025;120(10):2080-2093. doi:10.1111/add.70098

BibTeX
@article{Erinoso2025,
  author = {Erinoso, Olufemi and Kasza, Karin and Sheffer, Christine E and Hyland, Andrew and Pearson, Jennifer},
  title = {Use of cessation products, e‐cigarettes and cigarette cessation outcomes among adults with substance use problems: Results from 2013–2021 (Waves 1–6) of the Population Assessment of Tobacco and Health (PATH) Study},
  journal = {Addiction},
  year = {2025},
  volume = {120},
  number = {10},
  pages = {2080--2093},
  doi = {10.1111/add.70098}
}
Kostenlos starten →